Carl Atkinson to Immunosuppressive Agents
This is a "connection" page, showing publications Carl Atkinson has written about Immunosuppressive Agents.
Connection Strength
0.347
-
Nanotherapeutics in transplantation: How do we get to clinical implementation? Am J Transplant. 2022 05; 22(5):1293-1298.
Score: 0.146
-
Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy. Transplantation. 2017 04; 101(4):e75-e85.
Score: 0.104
-
A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor. Virol J. 2012 Nov 23; 9:285.
Score: 0.077
-
Targeting complement component 5a promotes vascular integrity and limits airway remodeling. Proc Natl Acad Sci U S A. 2013 Apr 09; 110(15):6061-6.
Score: 0.020